Hospital Universitario Príncipe de Asturias -ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2015

  1. Transarterial chemoembolisation in intermediate-Stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region

    Annals of Hepatology, Vol. 14, Núm. 2, pp. 207-217

1998

  1. Slow allotypic variants of the NAT2 gene and susceptibility to early- onset Parkinson's disease

    Neurology, Vol. 51, Núm. 6, pp. 1587-1592

1997

  1. Polymorphism is not associated with essential tremor

    European Neurology, Vol. 38, Núm. 2, pp. 99-104

1995

  1. Association between the oxidative polymorphism and early onset of Parkinson's disease

    Clinical Pharmacology and Therapeutics, Vol. 57, Núm. 3, pp. 291-298

1994

  1. Acetylator polymorphism in multiple sclerosis

    Acta Neurologica Scandinavica, Vol. 89, Núm. 2, pp. 102-104

1993

  1. Oxidative polymorphism of debrisoquine is not related to the risk of Alzheimer's disease

    Journal of the Neurological Sciences, Vol. 117, Núm. 1-2, pp. 8-11